Skip to main content
SpringerLink
Log in

Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate predictive factors for rapid engraftment after allogeneic peripheral blood stem cell transplantation (alloPBSCT) in patients with acute leukemia. Two hundred sixty-two patients receiving alloPBSCT were analyzed. Subset analyses of donor stem cells were conducted using a flow cytometric method. The correlation between rapid engraftment of neutrophils, platelets, and donor stem cells doses, as well as other recipient and donor clinical factors, was analyzed. In univariate analysis, factors correlated with neutrophil engraftment (≥0.5 × 109/L) by day 12 were achievement of complete remission (CR) after induction chemotherapy (CR1) before hematopoietic cell transplantation (HCT) and high numbers of CD34+ cells, CD3+ T cells, and CD3+/CD4+ T cells. Factors correlated with platelet engraftment (≥20 × 109/L) by day 12 were achievement of CR1 before HCT, donor and recipient sex mismatch, and high numbers of mononuclear cells, CD34+ cells, CD3+ T cells, CD3+/CD4+ T cells, CD3+/CD8+ T cells, and CD56+ NK cells. In multivariate analysis, independent predictive factors for rapid neutrophil and platelet engraftment were CR1 before HCT (p < 0.001 and p = 0.002, respectively), high number of donor CD34+ cells (p = 0.005 and p < 0.001, respectively), and high number of CD3+ T cells (p = 0.005 and p = 0.001, respectively). In conclusion, achieving CR1 before HCT, as well as larger quantities of donor CD34+ and CD3+ T cells, may predict rapid neutrophil and platelet engraftment after PBSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blaise D, Kuentz M, Fortanier C, Bourhis JH, Milpied N, Sutton L, Jouet J-P, Attal M, Bordigoni P, Cahn J-Y, Boiron J-M, Schuller M-P, Moatti J-P, Michallet M (2000) Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol 18(3):537–546

    PubMed  CAS  Google Scholar 

  2. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR, Hertenstein B, Klein JP, Montserrat E, Zhang M-J, Ringde'n O, Tomany SC, Rowlings PA, Van Hoef MEHM, Gratwohl A (2000) Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 95(12):3702–3709

    PubMed  CAS  Google Scholar 

  3. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers MED, Lilleby K, Chauncey TR, Storb R, Blume K, Heimfeld S, Rowley S, Appelbaum FR (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344(3):175–181. doi:10.1056/NEJM200101183440303

    Article  PubMed  CAS  Google Scholar 

  4. Ketterer N, Salles G, Raba M, Espinouse D, Sonet A, Tremisi P, Dumontet C, Moullet I, Eljaafari-Corbin A, Neidhardt-Berard E-M, Bouafia F, Coiffier B (1998) High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 91(9):3148–3155

    PubMed  CAS  Google Scholar 

  5. Ergene Ü, Çafirgan S, Pehlivan M, Yilmaz M, Tombuloflu M (2007) Factors influencing engraftment in autologous peripheral hematopoietic stem cell transplantation (PBSCT). Transfus Apher Sci 36(1):23–29

    Article  PubMed  Google Scholar 

  6. Olivieri A, Offidani M, Montanari M, Ciniero L, Cantori I, Ombrosi L, Masia CM, Centurioni R, Mancini S, Brunori M, Leoni P (1998) Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 83(4):329–337

    PubMed  CAS  Google Scholar 

  7. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13(10):2547–2555

    PubMed  CAS  Google Scholar 

  8. Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH (2001) Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. Bone Marrow Transplant 27(8):791–800. doi:10.1038/sj.bmt.1702872

    Article  PubMed  CAS  Google Scholar 

  9. Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J (1996) CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88(8):3223–3229

    PubMed  CAS  Google Scholar 

  10. Kamel AM, El-Sharkawy N, Mahmoud HK, Khalaf MR, El Haddad A, Fahmy O, El Fattah RA, Sayed D (2005) Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 35(2):129–136. doi:10.1038/sj.bmt.1704755

    Article  PubMed  CAS  Google Scholar 

  11. Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Von dem Borne AE, van der Schoot CE (1995) Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 13(8):1922–1932

    PubMed  CAS  Google Scholar 

  12. Prabhash K, Khattry N, Bakshi A, Karandikar R, Joshi A, Kannan S, Sastry PSRK, Parikh P, Kode JA (2010) CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment. Ann Oncol 21(3):582–588. doi:10.1093/annonc/mdp342

    Article  PubMed  CAS  Google Scholar 

  13. Kim DH, Won DI, Lee NY, Sohn SK, Suh JS, Lee KB (2006) Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Biol Blood Marrow Transplant 12(7):719–728

    Article  PubMed  CAS  Google Scholar 

  14. Bunjes D (2001) The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML. Cytotherapy 3(3):175–188

    Article  PubMed  CAS  Google Scholar 

  15. Gonçalves TL, Benvegnú DM, Bonfanti G (2009) Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation. Oxidative Med Cell Longev 2(2):82–87

    Article  Google Scholar 

  16. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85(2):588–596

    PubMed  CAS  Google Scholar 

  17. Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B, Flomenberg N, Burns J, Yang SY, Black P (1989) Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 74(6):2227–2236

    PubMed  CAS  Google Scholar 

  18. Burnett AK, Hann IM, Robertson AG, Alcorn M, Gibson B, McVicar I, Niven L, Mackinnon S, Hambley H, Morrison A (1988) Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation. Leukemia 2(5):300–303

    PubMed  CAS  Google Scholar 

  19. Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J (2008) Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 14(7):748–758. doi:10.1016/j.bbmt.2008.04.003

    Article  PubMed  Google Scholar 

  20. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115(3):453–474. doi:10.1182/blood-2009-07-235358

    Article  PubMed  Google Scholar 

  21. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J et al (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87(4):825–831

    Article  PubMed  CAS  Google Scholar 

  22. Reiffers J, Faberes C, Boiron JM, Marit G, Foures C, Ferrer AM, Cony-Makhoul P, Puntous M, Bernard P, Vezon G (1994) Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment. J Hematother 3(3):185–191

    Article  PubMed  CAS  Google Scholar 

  23. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86(10):3961–3969

    PubMed  CAS  Google Scholar 

  24. Shpall EJ, Champlin R, Glaspy JA (1998) Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 4(2):84–92

    Article  PubMed  CAS  Google Scholar 

  25. Spyridonidis A, Kuttler T, Wasch R, Samek E, Waterhouse M, Behringer D, Bertz H, Finke J (2005) Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin. Stem Cells Dev 14(2):213–222. doi:10.1089/scd.2005.14.213

    Article  PubMed  CAS  Google Scholar 

  26. Saliba RM, Komanduri KV, Giralt S, de Souza J, Patah P, Oran B, Couriel D, Rondon G, Champlin RE, de Lima M (2008) Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML. Bone Marrow Transplant 43(9):685–692

    Article  PubMed  Google Scholar 

  27. Warlick ED, Cioc A, DeFor T, Dolan M, Weisdorf D (2009) Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Biol Blood Marrow Transplant 15(1):30–38

    Article  PubMed  Google Scholar 

  28. Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Barbanti M, Sacchi N, Van Lint MT, Bosi A, for Gruppo Italiano Trapianti Midollo O (2001) Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 98(10):2942–2947. doi:10.1182/blood.V98.10.2942

    Article  PubMed  CAS  Google Scholar 

  29. Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb H-J, Bertz H, Egger M, Grishina O, Socié G (2009) Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 10(9):855–864. doi:10.1016/S1470-2045(09)70225-6

    Article  PubMed  CAS  Google Scholar 

  30. Pastore D, Mestice A, Perrone T, Gaudio F, Delia M, Albano F, RussoRossi A, Carluiccio P, Leo M, Liso V, Specchia G (2008) Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML. Bone Marrow Transplant 41(11):977–981

    Article  PubMed  CAS  Google Scholar 

  31. Cao TM, Shizuru JA, Wong RM, Sheehan K, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Stuart MJ, Grumet FC, Negrin RS, Lowsky R (2005) Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood 105(6):2300–2306. doi:10.1182/blood-2004-04-1473

    Article  PubMed  CAS  Google Scholar 

  32. Jakubowski AA, Small TN, Kernan NA, Castro-Malaspina H, Collins N, Koehne G, Hsu KC, Perales MA, Papanicolaou G, van den Brink MRM, O'Reilly RJ, Young JW, Papadopoulos EB (2011) T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biol Blood Marrow Transplant 17(9):1335–1342

    Article  PubMed  Google Scholar 

  33. Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteiza J, Ferrá C, Zuazu J, Caballero D, Carvalhais A, Díez JL, Espigado I, Martínez C, Campilho F, Sanz MA, Sierra J, García-Conde J, Montserrat E (2001) The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings. Blood 97(2):383–387. doi:10.1182/blood.V97.2.383

    Article  PubMed  CAS  Google Scholar 

  34. Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB (2002) The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 8(11):588–596

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea

    Ho Sup Lee, Lee Chun Park, Eun Mi Lee, Seong Hoon Shin & Yang Soo Kim

  2. Department of Hematology, Kyungpook National University Hospital, Daegu, South Korea

    Joon-Ho Moon

  3. Department of Internal Medicine, Busan Paik Hospital, Busan, South Korea

    Won Sik Lee

  4. Department of Internal Medicine, School of Medicine, Busan National University, 1-10 Ami-dong, Seo-gu, Busan, 602-739, South Korea

    Ho-Jin Shin & Joo-Seop Chung

  5. Department of Laboratory Medicine, Kosin University College of Medicine, Busan, South Korea

    Mi Hyang Kim

  6. Department of Occupational and Environmental Medicine, Kosin University College of Medicine, Busan, South Korea

    Byeong Jin Ye

Authors
  1. Ho Sup Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee Chun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eun Mi Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seong Hoon Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yang Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joon-Ho Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Won Sik Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ho-Jin Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mi Hyang Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Byeong Jin Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Joo-Seop Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joo-Seop Chung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, H.S., Park, L.C., Lee, E.M. et al. Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia. Ann Hematol 92, 1685–1693 (2013). https://doi.org/10.1007/s00277-013-1847-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1847-5

Keywords

Search

Navigation